nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Case of a Very Young Child With T Lymphoblastic Lymphoma With Eosinophilia and PDGFRB Translocation: A Rare Form of Myeloid/Lymphoid Neoplasm Associated With Eosinophilia and Rearrangements of PDGFRA, PDGFRB or FGFR1
|
Grimes, Amanda B. |
|
|
20 |
12 |
p. e990-e993 |
artikel |
2 |
Bortezomib, Lenalidomide, and Dexamethasone in Elderly Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm
|
Chahine, Claude |
|
|
20 |
12 |
p. e986-e989 |
artikel |
3 |
Clinical Significance of Increased FDG Uptake in the Waldeyer Ring and the Nasopharynx Region Identified by PET-CT in Postchemotherapy Follow-up in Patients With Lymphoma: When Should We Perform Biopsy?
|
Kurtoğlu, Erdal |
|
|
20 |
12 |
p. 830-835 |
artikel |
4 |
Daratumumab-induced Choroidal Effusion: A Case Report and Review of the Literature
|
Strong, Anne |
|
|
20 |
12 |
p. e994-e997 |
artikel |
5 |
Durable Complete Response to AMG 655 (Conatumumab) and Vorinostat in a Patient With Relapsed Classical Hodgkin Lymphoma: Extraordinary Response from a Phase 1b Clinical Protocol
|
Skelton IV, William Paul |
|
|
20 |
12 |
p. e944-e946 |
artikel |
6 |
Editorial Board
|
|
|
|
20 |
12 |
p. A5-A6 |
artikel |
7 |
Effect of Prophylactic Post-transplant Ponatinib Administration on Outcomes in Patients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia
|
Nanno, Satoru |
|
|
20 |
12 |
p. 813-819.e1 |
artikel |
8 |
Gemtuzumab Ozogamicin Combined With Intensive Chemotherapy in Patients With Acute Myeloid Leukemia Relapsing After Allogenic Stem Cell Transplantation
|
Genthon, Alexis |
|
|
20 |
12 |
p. 791-796 |
artikel |
9 |
Modified Hyper-CVAD With Proteasome Inhibition for Multiple Myeloma: A Single-Center Retrospective Analysis
|
Narayan, Rupa |
|
|
20 |
12 |
p. e961-e985 |
artikel |
10 |
Phase 1 Trial Evaluating Vorinostat Plus Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma
|
Kaufman, Jonathan L. |
|
|
20 |
12 |
p. 797-803 |
artikel |
11 |
Quality of Life and Symptom Burden With First- and Second-generation Tyrosine Kinase Inhibitors in Patients With Chronic-phase Chronic Myeloid Leukemia
|
Bostan, Hayri |
|
|
20 |
12 |
p. 836-842 |
artikel |
12 |
Radiation Dose Reduction in Early-Stage Hodgkin Lymphoma
|
Shah, Bhartesh A. |
|
|
20 |
12 |
p. 820-829 |
artikel |
13 |
Retrospective Analysis of the Clinical Use and Benefit of Lenalidomide and Thalidomide in Myelofibrosis
|
Castillo-Tokumori, Franco |
|
|
20 |
12 |
p. e956-e960 |
artikel |
14 |
Selinexor, Bortezomib, and Dexamethasone for Heavily Pretreated Multiple Myeloma: A Case Series
|
Magen, Hila |
|
|
20 |
12 |
p. e947-e955 |
artikel |
15 |
SOHO State of the Art Updates and Next Questions: Clonal Evolution in Chronic Lymphocytic Leukemia
|
Condoluci, Adalgisa |
|
|
20 |
12 |
p. 779-784 |
artikel |
16 |
Statins Reduce Mortality in Multiple Myeloma: A Population-Based US Study
|
Afzal, Amber |
|
|
20 |
12 |
p. e937-e943 |
artikel |
17 |
Surrogate Markers for Treatment-Free Remission in Patients With Chronic Myeloid Leukemia
|
Ureshino, Hiroshi |
|
|
20 |
12 |
p. 785-790 |
artikel |
18 |
Table of Contents
|
|
|
|
20 |
12 |
p. A7-A9 |
artikel |
19 |
Usefulness of Charlson Comorbidity Index to Predict Early Mortality and Overall Survival in Older Patients With Acute Myeloid Leukemia
|
Dhakal, Prajwal |
|
|
20 |
12 |
p. 804-812.e8 |
artikel |
20 |
WT1 Expression in Peripheral Blood at Diagnosis and During the Course of Early Consolidation Treatment Correlates With Survival in Patients With Intermediate and Poor-Risk Acute Myeloid Leukemia
|
Šálek, Cyril |
|
|
20 |
12 |
p. e998-e1009 |
artikel |